# Effectiveness and Clinical Predictors of Virtual Group Therapy for Cannabis Use Disorder > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/virtual-group-therapy-cannabis-use-disorder-effectiveness/ > **Published:** 2026-03-24T21:03:36-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:08:42-04:00 > **Clinical Summary:** Explore virtual group therapy cannabis use disorder effectiveness and clinical predictors in adults using combined CBT and motivational enhancement therapy. --- CED Clinical Relevance  #72Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. 🔬 Evidence Watch  |  CED Clinic [Cannabis Use Disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/)CbtVirtual Therapy[Addiction Medicine](https://cedclinic.com/cognitive-flexibility-alcohol-cocaine-misuse-effects/)Treatment Outcomes Journal Drug and alcohol dependence Study Type [Clinical Study](https://cedclinic.com/cannabis-hyperemesis-syndrome-psychiatric-risk/) Population Human participants Why This Matters [Cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) disorder affects millions of adults, yet access to evidence-based treatment remains limited. Virtual delivery of combined CBT-MET could dramatically expand treatment availability, making this effectiveness research clinically relevant for [addiction medicine](https://cedclinic.com/cognitive-flexibility-alcohol-cocaine-misuse-effects/) practitioners. Clinical Summary This retrospective analysis evaluated 116 adults in a 12-week virtual group CBT-MET program for [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/) between 2020-2023. Participants showed significant reductions in [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) frequency, craving scores, and problematic use measures among treatment completers (≥75% attendance). The study also tracked depression and anxiety symptoms biweekly, though specific outcome data on these measures wasn’t provided in the abstract. As a retrospective analysis without a control group, the study cannot establish causation, but provides real-world effectiveness data for virtual delivery of this evidence-based intervention combination. Dr. Caplan’s Take “Virtual group therapy for cannabis use disorder appears promising based on these completion rates and symptom improvements. However, I need randomized controlled data before recommending this as equivalent to in-person treatment for my patients with moderate to severe cannabis use disorder.” Clinical Perspective 🧠 Clinicians should consider virtual CBT-MET programs as a viable treatment option, particularly for patients with geographic or scheduling barriers to in-person care. The key appears to be ensuring adequate treatment engagement, as outcomes were measured only among those with high attendance rates. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Effectiveness%20and%20clinical%20predictors%20of%20a%20virtual%20based%20combined%20cognitive%20beha...%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41546985/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41546985/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Effectiveness%20and%20clinical%20predictors%20of%20a%20virtual%20based%20combined%20cognitive%20beha...%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41546985/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41546985/](https://pubmed.ncbi.nlm.nih.gov/41546985/) Table of Contents - [FAQ](#FAQ)[How effective is virtual CBT-MET group therapy for cannabis use disorder?](#How_effective_is_virtual_CBT-MET_group_therapy_for_cannabis_use_disorder) - [What are the advantages of delivering CBT-MET virtually for cannabis use disorder?](#What_are_the_advantages_of_delivering_CBT-MET_virtually_for_cannabis_use_disorder) - [What baseline factors predict better treatment outcomes in virtual CBT-MET for cannabis use disorder?](#What_baseline_factors_predict_better_treatment_outcomes_in_virtual_CBT-MET_for_cannabis_use_disorder) - [How long should patients engage in virtual CBT-MET therapy for optimal results?](#How_long_should_patients_engage_in_virtual_CBT-MET_therapy_for_optimal_results) - [Can virtual group therapy replace in-person treatment for cannabis use disorder?](#Can_virtual_group_therapy_replace_in-person_treatment_for_cannabis_use_disorder) - [Related](#Related) ## FAQ #### How effective is virtual CBT-MET group therapy for cannabis use disorder? This 12-week virtual group-based CBT-MET program demonstrated clinical efficacy for adults with cannabis use disorder. Participants who completed at least 75% of sessions showed significant improvements in cannabis use patterns, craving levels, depression, and anxiety symptoms based on validated assessment tools. #### What are the advantages of delivering CBT-MET virtually for cannabis use disorder? Virtual delivery of CBT-MET provides increased accessibility and convenience for patients with cannabis use disorder, removing geographical and transportation barriers. This study’s findings suggest that virtual group therapy can maintain therapeutic effectiveness while potentially reaching more patients who might not otherwise access in-person treatment. #### What baseline factors predict better treatment outcomes in virtual CBT-MET for cannabis use disorder? The study examined baseline predictors of treatment response using linear mixed models, though specific predictor results aren’t detailed in the available summary. Identifying these predictors helps clinicians determine which patients are most likely to benefit from virtual CBT-MET interventions. #### How long should patients engage in virtual CBT-MET therapy for optimal results? The study used a 12-week program format and defined treatment completion as ≥75% attendance, suggesting this duration and engagement level are necessary for therapeutic benefit. Patients who met this attendance threshold showed significant improvements across multiple clinical measures including cannabis use, craving, depression, and anxiety. #### Can virtual group therapy replace in-person treatment for cannabis use disorder? This study provides evidence that virtual CBT-MET group therapy can be an effective treatment modality for cannabis use disorder, producing meaningful clinical improvements. However, treatment selection should be individualized based on patient preferences, baseline characteristics, and clinical judgment regarding the most appropriate delivery format. {“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “Effectiveness and clinical predictors of a virtual based combined cognitive behavioral and motivational enhancement group therapy for adults with cannabis use disorder.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41546985/”, “about”: “drug alcohol dependence [clinical study](https://cedclinic.com/cannabis-hyperemesis-syndrome-psychiatric-risk/) effectiveness”, “isPartOf”: “Drug and alcohol dependence”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabis Use Patterns and Perception of Acute Pain During Brief Abstinence](https://cedclinic.com/acute-pain-cannabinoid-withdrawal-sex-dependent-cannabis-study/) Explore sex-dependent associations between cannabis use patterns and pain perception during abstinence. [Read More](https://cedclinic.com/acute-pain-cannabinoid-withdrawal-sex-dependent-cannabis-study/) [Medical Cannabis Linked to Meaningful Pain-Related Improvements](https://cedclinic.com/medical-cannabis-linked-to-meaningful-pain-related-improvements-in-large-minnesota-study/) Review findings from a large Minnesota study on [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) and pain relief outcomes. [Learn More](https://cedclinic.com/medical-cannabis-linked-to-meaningful-pain-related-improvements-in-large-minnesota-study/) [Effectiveness of Cognitive Behavioral Therapy for Harmful Cannabis Use](https://cedclinic.com/cognitive-behavioral-therapy-cannabis-use-disorder-effectiveness/) An analysis of CBT effectiveness in treating harmful cannabis use with clinical insights. [Explore Study](https://cedclinic.com/cognitive-behavioral-therapy-cannabis-use-disorder-effectiveness/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).